Publications for Christina Hedman
Co-author map based on ISI articles 2007-

Journal Articles

Christina A Hedman, Jan Frystyk, Torbjörn Lindström, Per Oskarsson and Hans J Arnqvist
  Intraperitoneal insulin delivery to patients with type 1 diabetes results in higher serum IGF-I bioactivity than continuous subcutaneous insulin infusion
  Clinical Endocrinology, 2014, 81(1), 58-62.
 Web of Science® Times Cited: 1

Torbjörn Lindström, Jan Frystyk, Christina Hedman, Allan Flyvbjerg and Hans Arnqvist
  Elevated circulating adiponectin in type 1 diabetes is associated with long diabetes duration
  Clinical Endocrinology, 2006, 65(6), 776-782.
 Web of Science® Times Cited: 16

Christina Hedman, Jan Frystyk, Karin Fridell, Anna Jönsson, Allan Flyvbjerg, Torbjörn Lindström and Hans Arnqvist
  The IGF-system is not affected by a twofold change in protein intake in patients with type 1 diabetes
  Growth Hormone & IGF Research, 2005, 15(4), 304-310.
 Web of Science® Times Cited: 3

Christina Hedman, Jan Frystyk, Torbjörn Lindström, Jian-Wen Chen, Allan Flyvbjerg, Hans Ørskov and Hans Arnqvist
  Residual β-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes
  Journal of Clinical Endocrinology and Metabolism, 2004, 89(12), 6305-6309.
 Web of Science® Times Cited: 28

Torbjörn Lindström, Christina Hedman and Hans Arnqvist
  Use of a novel double-antibody technique to describe the pharmacokinetics of rapid-acting insulin analogs
  Diabetes Care, 2002, 25(6), 1049-1054.
 Web of Science® Times Cited: 22

Christina Hedman, Torbjörn Lindström and Hans Arnqvist
  Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes
  Diabetes Care, 2001, 24, 1120-1121.
 Web of Science® Times Cited: 40

Christina Hedman, A-C Orre-Pettersson, Torbjörn Lindström and Hans Arnqvist
  Treatment with insulin lispro changes the insulin profile but does not affect the plasma concentrations of IGF-I and IGFBP-1 in type 1 diabetes
  Clinical Endocrinology, 2001, 55(1), 107-112.
 Web of Science® Times Cited: 12

Conference Articles

Christina Hedman, J Frystyk, Torbjörn Lindström, P Oskarsson and Hans Arnqvist
  Intraperitoneal insulin delivery gives higher circulating IGF-I activity than CSII in type 1 diabetes
  in DIABETOLOGIA, vol 52, 2009.

Ph.D. Theses

Christina Hedman
  Insulin and IGF-I in type 1 diabetes